OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) - VITAE PHARMACEUTICALS INC ownership

VITAE PHARMACEUTICALS INC's ticker is VTAE and the CUSIP is 92847N103. A total of 71 filers reported holding VITAE PHARMACEUTICALS INC in Q2 2016. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) ownership history of VITAE PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2016$1,227,000,000185,0000.02%
Other shareholders

There were no reported owners of VITAE PHARMACEUTICALS INC in Q2 2016.

NameSharesValueWeighting ↓
View complete list of VITAE PHARMACEUTICALS INC shareholders